Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07231822 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients

StatusRecruiting
PhaseNot applicable
Started2025-11-20
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 27, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-02-25
minor
Study Status v3
Re-verified, no change to tracked fields
2025-12-13
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Study sites0→1
2025-11-16
minor
Study Status, Eligibility v1
2025-11-14
minor
Original filing
Osteoporosis is a progressive disease characterised by a decrease in bone mass, deterioration in bone microarchitecture, and increased fragility. Etiologically, it is divided into two types: primary (postmenopausal and senile) and secondary. Postmenopausal women are particularly at high risk; it is seen in more than 80% of women over the age of 50 and in almost all individuals over the age of 75. With menopause, bone mineral density decreases, which negatively affects neuromuscular functions, leading to balance disorders, decreased walking speed, and an increased risk of falls. Falls are the primary cause of osteoporotic fractures and result in functional loss, morbidity, mortality, and increased healthcare costs. Exercise is effective in reducing bone loss; in recent years, therapeutic virtual reality and exercise games (exergames) have come to the fore. However, the literature on the effectiveness of these applications in postmenopausal osteoporosis patients is limited. The aim of this study is to investigate the effects of virtual reality applications on balance, quality of life, and fall risk and to compare them with a control group.
Trial Details
NCT Number NCT07231822
Lead Sponsor Kirsehir Ahi Evran Universitesi
Conditions Osteoperosis
Enrollment 50 participants
Start Date 2025-11-20
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-27